First Trust Nasdaq Pharmaceuticals ETF (FTXH) to Issue Quarterly Dividend of $0.12 on September 30th

Posted by Latisha Jones on Sep 27th, 2024

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH – Get Free Report) declared a quarterly dividend on Wednesday, September 25th, NASDAQ reports. Stockholders of record on Thursday, September 26th will be given a dividend of 0.1218 per share on Monday, September 30th. This represents a $0.49 dividend on an annualized basis and a dividend yield of 1.70%. The ex-dividend date is Thursday, September 26th.

First Trust Nasdaq Pharmaceuticals ETF Price Performance

NASDAQ:FTXH opened at $28.59 on Friday. The company has a fifty day moving average price of $28.87 and a 200 day moving average price of $27.69. First Trust Nasdaq Pharmaceuticals ETF has a one year low of $23.85 and a one year high of $29.72. The stock has a market cap of $18.58 million, a P/E ratio of 15.98 and a beta of 0.70.

First Trust Nasdaq Pharmaceuticals ETF Company Profile

(Get Free Report)

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.